Scientists map immune cells in colon cancer patients
NCT ID NCT03015038
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at immune cells in the blood and tumor tissue of 100 people with colon cancer. Researchers measured T cells and other white blood cells to understand the body's immune response. The goal was to gather knowledge, not to test a new treatment. Participants provided samples and were followed for up to 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help scientists better understand how the immune system reacts to colon cancer, potentially guiding future treatments.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly help patients. Results may not lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Saint Louis
Paris, 75000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can radiation plus immunotherapy make colon tumors disappear before surgery?
- Gut bacteria may shield nerves from chemo damage – a trial puts it to the test
- New drug combo aims to boost surgery success in colon cancer
- Blood test and AI team up to outsmart colon cancer recurrence
- Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
- Blood test guides next move against stubborn colon cancer